Investor's Business Daily on MSN3mon
Monte Rosa Almost Doubles — Up 94% — On A Massive Deal With Novartis
Monte Rosa Therapeutics bounded higher on Monday, as shares nearly doubled on a deal with Novartis to develop treatments for ...
Yahoo Finance1mon
Monte Rosa Therapeutics provides development progress on ongoing MRT-2359 study
https://www.tipranks.com/news/the-fly/streamline-health-expands-presence-in-texas-with-400-bed-health-system Monte Rosa Therapeutics (GLUE) reported an update from ...
Nasdaq1mon
Monte Rosa downgraded to Equal Weight from Overweight at Wells Fargo
Wells Fargo analyst Derek Archila downgraded Monte Rosa Therapeutics (GLUE) to Equal Weight from Overweight with a price arget of $11, down from $14. The firm thinks the stock’s upside is ...
Nasdaq23d
Monte Rosa Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
BOSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines ...